Salesforce Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy

59

CRM
Salesforce

Last Price:

252.93

Seasonality Move:

9.27%

Sell

44

RARE
Ultragenyx Pharmaceutical

Last Price:

41.40

Seasonality Move:

-0.9%

Buy

59

Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

The current Salesforce [CRM] share price is $243.15. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

44

Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

The Salesforce share price today is $243.15
The current trend is relatively stagnant and CRM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

CRM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-6.88	Sell
Relative Strength Index (14 RSI):	45.72	Sell
Chaikin Money Flow:	3157474	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(228.19 - 264.49)	Sell
Bollinger Bands (100):	(255.74 - 303.84)	Sell

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.6	Sell
Relative Strength Index (14 RSI):	49.22	Sell
Chaikin Money Flow:	494801	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(38.79 - 41.97)	Buy
Bollinger Bands (100):	(40.81 - 48.79)	Sell

CRM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	238.24	Buy
20-day SMA:	238.51	Buy
50-day SMA:	261.41	Sell
200-day SMA:	256.91	Sell
8-day EMA:	240.21	Buy
20-day EMA:	244.2	Sell
50-day EMA:	258.24	Sell
200-day EMA:	256.25	Sell

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	39.2	Buy
20-day SMA:	40.42	Buy
50-day SMA:	41.53	Sell
200-day SMA:	42.45	Sell
8-day EMA:	39.89	Buy
20-day EMA:	40.39	Buy
50-day EMA:	41.79	Sell
200-day EMA:	43.35	Sell

Salesforce Earnings Growth & CRM Earnings Dates

Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.22 per share, an increase this year of $3.27 per share, and an increase next year of $1.70 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Salesforce Technical Analysis

	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26
	Jun
	12	13	14	17	18	20	21	24	25	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

	Jun 12	Jun 13	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26
	Jun
	12	13	14	17	18	20	21	24	25	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):